Salipro Biotech is participating (virtually) at BioJapan 2024 from October 9-11! Our Business Development team is ready to connect one-on-one with pharma and biotech companies to discuss potential collaborations focused on drug development targeting challenging membrane proteins.
If you are attending, reach out to us via the BioJapan partnering platform to schedule a virtual meeting. We look forward to exploring new opportunities with the Salipro® technology in Japan!
Link to BioJapan: https://jcd-expo.jp/en/
Salipro at BioJapan 2024
Previous
Previous
Salipro Biotech and Top10 Japanese Pharma Company Expand Multi-Target Research Collaboration
Next
Next